ISRCTN13692671
Active, not recruiting
未知
Health-related Quality of Life and survivorship in Locally Recurrent Rectal Cancer. The LRRC-QoL study
niversity of Leeds0 sites320 target enrollmentDecember 20, 2021
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health-related quality of life and survivorship in locally recurrent rectal cancer
- Sponsor
- niversity of Leeds
- Enrollment
- 320
- Status
- Active, not recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Workstream I:
- •1\.1 Aged over or equal to 18 years
- •1\.2 Radiological and/or histological diagnosis of locally recurrent rectal cancer
- •1\.3 Undergone treatment for locally recurrent rectal cancer within the last 2 years
- •1\.4 Able to provide informed written consent to participate
- •1\.5 Able to read and write in the target language.
- •Workstream II:
- •2\.1 Aged over or equal to 18 years
- •2\.2 New radiological and/or histological diagnosis of locally recurrent rectal cancer
- •2\.3 Able to provide informed written consent to participate
Exclusion Criteria
- •1\. Patients with cognitive impairment
- •2\. Patients who are in remission from treatment of primary rectal cancer with no evidence of local recurrence
- •3\. Patients who are receiving treatment for distant metastatic disease following previous treatment of rectal cancer with no evidence of local recurrence
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Predictors of survival rate and quality of life in children undergoing Blalock-Taussig shunt at Songklanagarind hospitalquality of lifesurvival rateBlalock Taussig shuntTCTR20161221003Faculty of Medicine, Prince of Songkla university522
Not yet recruiting
Phase 4
Factors that affect health related quality of life in cardiogenic shock survivorsCTRI/2022/10/046489Heart Failure Association of India HFAI
Recruiting
Not Applicable
Quality of life, Survival, COmorbidities, and Pharmacoeconomics in Elderly patients with Acute Myeloid LeukemiaBloodcancerLeukeamia10024324NL-OMON53259Medisch Centrum Leeuwarden100
Active, not recruiting
Phase 1
Pembrolizumab (MK-3475) in elderly patients with non-small cell lung cancerEUCTR2016-004353-32-ESSpanish Lung Cancer Group (SLCG/GECP)
Completed
Not Applicable
Quality of life assessment and overall survival in patients with mulitple myeloma after Tandem Autologous Stem Cell Transplantation (ASCT)ACTRN12609000595213Clifford Craig Medical Research Trust40